Intrathecal ropivacaine in cancer pain.
Mercadante
S
S
Calderone
L
L
Barresi
L
L
D000368:Aged; D000577:Amides / Q000008:administration & dosage / Q000627:therapeutic use*; D000698:Analgesia / Q000379:methods*; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000627:therapeutic use; D000779:Anesthetics, Local / Q000008:administration & dosage / Q000627:therapeutic use*; D002045:Bupivacaine / Q000008:administration & dosage / Q000627:therapeutic use; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005260:Female; D005833:Genital Neoplasms, Female / Q000503:physiopathology*; D006801:Humans; D007278:Injections, Spinal; D008160:Lumbosacral Plexus / Q000187:drug effects; D009020:Morphine / Q000008:administration & dosage / Q000627:therapeutic use; D010146:Pain / Q000517:prevention & control*; D010147:Pain Measurement; D000077212:Ropivacaine
D000577:Amides; D000701:Analgesics, Opioid; D000779:Anesthetics, Local; D009020:Morphine; D000077212:Ropivacaine; D002045:Bupivacaine